Making our world safer through science: Identifying novel biomarkers of COVID-19 in breath

Breath testing has been proposed as an elegant, non-invasive method to provide rapid diagnosis of diseases – from cancer to COVID-19 – enabling the delivery of precision medicine.

Our guest speaker, Dr Amalia Berna from the Children’s Hospital of Philadelphia, will then discuss the application of this state-of-the-art technology to identify breath biomarkers associated with COVID-19 infection in children, allowing it to be quickly differentiated from other respiratory illnesses.

By attending this webinar you will:

• Find out how thermal desorption (TD) provides sample security and integrity in breath biomarker workflows
• See how two-dimensional gas chromatography (GC×GC) allows you to discover more from breath samples
• Learn about the advantages of BenchTOF2 mass spectrometers for sensitive detection, confident identification and easy-to-use workflows
• See how smart software tools can automatically ‘spot the difference’ between breath profiles
• Hear about the real-world application of this technology for the detection of biomarkers associated with COVID-19.

Presenter: Dr Amalia Berna (Children’s Hospital of Philadelphia)